Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ana Belen Enguita"'
Autor:
Irene Ruiz-Martin, Ignacio Garcia-Recuero, Maria Urbanowicz, Ignacio Zubillaga-Rodriguez, Marta Redondo-Alamillos, Alvaro Rivero-Calle, Claudio Ballestin-Carcavilla, Ana Belen Enguita, Ana Isabel Romance, Gregorio Sanchez-Aniceto
Publikováno v:
Oral and Maxillofacial Surgery Cases, Vol 2, Iss 4, Pp 40-45 (2016)
Background: Spindle cell carcinoma (SpCC) is an infrequent and aggressive type of squamous cell carcinoma (SCC) characterized by the proliferation of epithelial and mesenchymal components. Oral SCC in children is an extremely rare entity and the SpCC
Externí odkaz:
https://doaj.org/article/e25f2b0fc94d4c6f9315e8da28961a6f
Autor:
Ana-Belen Enguita-Valls, Ricardo Ruiz-Rodríguez, Ignacio Sanchez-Carpintero, Alejandro Martin-Gorgojo
Publikováno v:
Dermatopathology, Vol 8, Iss 47, Pp 446-449 (2021)
Dermatopathology
Dermatopathology
A case of a purely eccrine nevus in an adolescent patient presenting with focal hyperhidrosis on an area comprising the left forearm and the dorsal aspect of the left hand is described. No clinically evident lesions were identifiable. Dermatopatholog
Autor:
Javier Ramos-Paradas, David Gomez-Sanchez, Aranzazu Rosado, Alvaro Conrado Ucero, Nuria Carrizo, Ana Belen Enguita, Maria Teresa Muñoz, Esther Conde, Luis Paz-Ares, Eva Maria Garrido-Martin
Publikováno v:
Cancer Research. 82:1245-1245
Lung cancer has the second highest incidence and leads cancer mortality worldwide, being Non-Small Cell Lung Cancer (NSCLC) the most prevalent subtype. Immunotherapy with checkpoint blockers has shown outstanding benefits in a subset of NSCLC patient
Autor:
Mercedes Herrera, Álvaro C. Ucero, Ana Belen Enguita, Nuria Carrizo, Ramon Yarza, Igor Gómez-Randulfe, Helena Bote-de-Cabo, Javier Baena, Esther García-Lorenzo, Jon Zugazagoitia, Luis G. Paz-Ares
Publikováno v:
Journal of Clinical Oncology. 40:8562-8562
8562 Background: Malignant Pleural Mesothelioma (MPM) has been characterized by an immune suppressive microenvironment. The immune checkpoint (IC) VISTA is notably expressed in MPM, in contrast to other IC proteins such us PD-L1. Recently, CD47 has b
Autor:
Lara Iglesias, Ana Belen Enguita, Ramon Yarza, Marisa Durán, Justino Jiménez Almonacid, Neus Baste, Alberto Carral Maseda, Marc Oliva, Pedro Perez Segura, Ana Medina-Colmenero, Beatriz Cirauqui, Virginia Arrazubi, Vanesa Gutierrez Calderon, Javier Martinez-Trufero, Edel del Barco Morillo, Almudena García Castaño, Jordi Rubió-Casadevall, Laura Basterretxea, Irene Brana, Ricard Mesia
Publikováno v:
Journal of Clinical Oncology. 40:e18015-e18015
e18015 Background: PD-L1 is a biomarker of response to anti-PD1 in HNSCC. CA209-7HE trial (NCT04282109) is a randomized, open-label, multicenter, phase II trial including first line R/M HNSCC pts non-eligible for cisplatin-based chemotherapy. Pts wer
Autor:
Sandra Falagan, Amparo Benito, X. Mielgo, Enrique Casado, Isabel Alemany, María Sereno, Juan Moreno-Rubio, M. Cebollero, Ana Belen Enguita Valls, Rosa Alvarez, Sagrario Garcia, Fatima Navarro Expósito, Carolina Castillo, Santiago Ponce Aix, Maria Eugenia Olmedo Garcia, Ricardo Luiz Ramos
Publikováno v:
Journal of Clinical Oncology. 36:e21128-e21128
e21128Background: Long survivors (LS) in non-small-cell lung cancer (NSCLC), defined as an overall survival (OS) greater than 2 years, are less than 10% in most series. Classical prognosis factors ...
Autor:
Antolina Gómez López, Arschang Valipour, Eduardo de Miguel Poch, Ricardo García Luján, Roberto del Pozo Rivas, Raquel Pérez Rojo, Ana Belén Enguita Vals, Sergio Alonso Charterina, Ignacio de Granda Orive, Carlos José Álvarez Martínez, Virginia Pérez González, Pablo Gámez García, Manuel Cortés Guerrero, Victoria Villena Garrido
Publikováno v:
Open Respiratory Archives, Vol 5, Iss 2, Pp 100242- (2023)
Externí odkaz:
https://doaj.org/article/13a33ce72b5f436c9c96432fb7bd2077
Autor:
Enrique Recuero, Sara Lázaro, Corina Lorz, Ana Belén Enguita, Ramón Garcia-Escudero, Mirentxu Santos
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 20, p 15284 (2023)
There is a clear need to expand the toolkit of adequate mouse models and cell lines available for preclinical studies of high-grade neuroendocrine lung carcinoma (small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC)). SCLC
Externí odkaz:
https://doaj.org/article/451d9ffa33f04763a6139002cf12b765
Publikováno v:
Journal of thoracic disease. 6(Suppl 5)
The new the International Association for the Study of Lung Cancer (IASLC)/the American Thoracic Society (ATS)/the European Respiratory Society (ERS) pathologic classification of lung cancer has markedly changed the pathologic diagnosis of lung adeno
Autor:
Juan Moreno-Rubio, Santiago Ponce, Rosa Álvarez, María Eugenia Olmedo, Sandra Falagan, Xabier Mielgo, Fátima Navarro, Patricia Cruz, Luis Cabezón-Gutiérrez, Carlos Aguado, Gonzalo Colmenarejo, Marta Muñoz-Fernández de Leglaria, Ana Belén Enguita, María Cebollero, Amparo Benito, Isabel Alemany, Carolina del Castillo, Ricardo Ramos, Ana Ramírez de Molina, Enrique Casado, Maria Sereno
Publikováno v:
Cancer Biology & Medicine, Vol 17, Iss 2, Pp 444-457 (2020)
Objective: Long-term survivors (LS) of non-small cell lung cancer (NSCLC) without driver alterations, displaying an overall survival (OS) of more than 3 years, comprise around 10% of cases in several series treated with chemotherapy. There are classi
Externí odkaz:
https://doaj.org/article/36439633311a4ff2ae4cf60b69f45489